The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
Open accessAbstract
The absorption of oral drugs is frequently plagued by significant variability with potentially serious therapeutic consequences. The source of variability can be traced back to interindividual variability in physiology, differences in special populations (age- and disease-dependent), drug and formulation properties, or food-drug interactions. Clinical evidence for the impact of some of these factors on drug pharmacokinetic variability is mounting: e.g. gastric pH and emptying time, small intestinal fluid properties, differences in pediatrics and the elderly, and surgical changes in gastrointestinal anatomy. However, the link of colonic factors variability (transit time, fluid composition, microbiome), sex differences (male vs. female) and gut-related diseases (chronic constipation, anorexia and cachexia) to drug absorption variability has not been firmly established yet. At the same time, a way to decrease oral drug pharmacokinetic variability is provided by the pharmaceutical industry: clinical evidence suggests that formulation approaches employed during drug development can decrease the variability in oral exposure. This review outlines the main drivers of oral drug exposure variability and potential approaches to overcome them, while highlighting existing knowledge gaps and guiding future studies in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–332 of 332
The Effect of Mannitol on the Oral Bioavailability of Cimetidine
Adkin, D. A., Davis, S. S., Sparrow, R. A., Huckle, P. D., & Wilding, I. R. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841205 · Cited by 79
Zhu, H., Xu, G., Zhang, K., Kong, X., Han, R., Zhou, J., & Ni, Y. (2016) · Scientific Reports · doi:10.1038/srep27779 · Cited by 79
Ruiter, R., Burggraaf, J., & Rißmann, R. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13876 · Cited by 79
Reppas, C. I., Karatza, E., Goumas, C., Markopoulos, C., & Vertzoni, M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1710-6 · Cited by 76
Self-citationBrantley, R. K., Williams, K. R., Silva, T. M. J., Sistrom, M. G., Thielman, N. M., Ward, H., Lima, A. Â. M., & Guerrant, R. L. (2003) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702003000100003 · Cited by 76
Colonic transit time—what is normal?
Wagener, S., Shankar, K. R., Turnock, R. R., Lamont, G. L., & Baillie, C. T. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2003.10.002 · Cited by 76
Prokinetic drugs for feed intolerance in critical illness: current and potential therapies
Deane, A. M., Fraser, R. J., & Chapman, M. J. (2009) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01538-7 · Cited by 75
Chronic Idiopathic Constipation: More Than A Simple Colonic Transit Disorder
Shahid, S., Ramzan, Z., Maurer, A. H., Parkman, H. P., & Fisher, R. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318231fc64 · Cited by 75
The gut in Parkinson’s disease: Bottom‐up, top‐down, or neither?
Leclair‐Visonneau, L., Neunlist, M., Derkinderen, P., & Lebouvier, T. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13777 · Cited by 75
Teitelbaum, E. N., Vaziri, K., Zettervall, S. L., AMDUR, R. L., & Orkin, B. A. (2013) · Clinical Anatomy · doi:10.1002/ca.22238 · Cited by 74
Role of enterohepatic recirculation in drug disposition: cooperation and complications
Malik, M. Y., Jaiswal, S., Sharma, A., Shukla, M. K., & Lal, J. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2016.1157600 · Cited by 71
Pentafragka, C., Symillides, M., McAllister, M. S., Dressman, J., Vertzoni, M., & Reppas, C. I. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12999 · Cited by 71
Self-citationGay, C., Toulet, D., & Corre, P. L. (2016) · Hematological Oncology · doi:10.1002/hon.2335 · Cited by 69
Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
Tandra, S., Chalasani, N., Jones, D. R., Mattar, S. G., Hall, S. D., & Vuppalanchi, R. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31827a0e82 · Cited by 68
Persson, E. M., Nilsson, R. G., Hansson, G. I., Löfgren, L., Libäck, F., Knutson, L., Abrahamsson, B., & Lennernäs, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9607-z · Cited by 68
Aoyagi, N., Ogata, H., Kaniwa, N., Uchiyama, M., Yasuda, Y., & Tanioka, Y. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600811208 · Cited by 68
Bisschop, P. H. L. T., Bandsma, R., Stellaard, F., ter Harmsel, A., Meijer, A. J., Sauerwein, H. P., Kuipers, F., & Romijn, J. A. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.570 · Cited by 68
Rahmouni, M. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00127-8 · Cited by 67
Li, L., Wang, L., Shao, Y., Ni, R., Zhang, T., & Mao, S. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.052 · Cited by 67
Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics
Gao, Y., Shao, J., Zhou, J., Chen, J., Gu, S., Yu, S., Zheng, K., & Jia, L. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.020 · Cited by 67
Sugihara, M., Takeuchi, S., Sugita, M., Higaki, K., Kataoka, M., & Yamashita, S. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00602 · Cited by 67
L-Thyroxine Absorption in Patients with Short Bowel
STONE, E., LEITER, L. A., LAMBERT, J. R., SILVERBERG, J. D. H., JEEJEEBHOY, K. N., & BURROW, G. N. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-139 · Cited by 66 · cited 1×
“both of which are absorbed distally to the duodenojejunal flexure (Stone et al., 1984; Ueno et al., 1995).”
BackgroundFranken, L. G. W., de Winter, B. C. M., van Esch, H. J., van Zuylen, L., Baar, F. P. M., Tibboel, D., Mathôt, R. A. A., van Gelder, T., & Koch, B. C. P. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1179281 · Cited by 66
Müllertz, A., Fatouros, D. G., Smith, J. R., Vertzoni, M., & Reppas, C. I. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200286x · Cited by 65
Self-citationThe Physiology of Gastric Motility and Gastric Emptying
Hasler, W. L. (2008) · Textbook of Gastroenterology · doi:10.1002/9781444303254.ch10 · Cited by 63
Li, X., Lindquist, S., Lowe, M. E., Noppa, L., & Hernell, O. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3181559e75 · Cited by 63
Colonic bacterial metabolism of corticosteroids
Yadav, V., Gaisford, S., Merchant, H. A., & Basit, A. W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.09.007 · Cited by 63
Self-citationKarsdal, M. A., Byrjalsen, I., Riis, B. J., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-5 · Cited by 63
Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility
Maharaj, A. R., Edginton, A. N., & Fotaki, N. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1762-7 · Cited by 62
Prediction of human pharmacokinetics—biliary and intestinal clearance and enterohepatic circulation
Fagerholm, U. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0001 · Cited by 62
Yeung, C. H. T., Fong, S., Malik, P. R. V., & Edginton, A. N. (2020) · Maternal and Child Nutrition · doi:10.1111/mcn.12938 · Cited by 62
Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
Coombes, Z., Yadav, V., McCoubrey, L. E., Freire, C., Basit, A. W., Conlan, R. S., & González, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080760 · Cited by 62
Self-citationNovel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300769 · Cited by 61
Effect of Meal Ingestion on Ileocolonic and Colonic Transit in Health and Irritable Bowel Syndrome
Deiteren, A., Camilleri, M., Burton, D. D., McKinzie, S., Rao, A. S., & Zinsmeister, A. R. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1041-8 · Cited by 60
Rubbens, J., Brouwers, J., Tack, J. F., & Augustijns, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.014 · Cited by 60
Self-citationMeal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients
Carver, P. L., Fleisher, D., Zhou, S. Y., Kaul, D. R., Kazanjian, P. H., & Li, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018880726035 · Cited by 59
Lavrijsen, K., Dyck, D. V., Houdt, J. V., Hendrickx, J., Monbaliu, J. G., Woestenborghs, R. J. H., Meuldermans, W., & Heykants, J. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06545-6 · Cited by 59
Gotch, F. A., Nadell, J., & Edelman, I. S. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103423 · Cited by 57
Trevaskis, N. L., Shackleford, D. M., Charman, W. N., Edwards, G. A., Gardin, A., Appel‐Dingemanse, S., Kretz, O., Galli, B., & Porter, C. J. H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9860-z · Cited by 55
Self-citationWuyts, B., Riethorst, D., Brouwers, J., Tack, J. F., Annaert, P., & Augustijns, P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.021 · Cited by 55
Self-citationWuyts, B., Riethorst, D., Brouwers, J., Tack, J. F., Annaert, P., & Augustijns, P. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.11.010 · Cited by 54
Self-citationHuman colonic motility: physiological aspects
Bassotti, G., Germani, U., & Morelli, A. (1995) · International Journal of Colorectal Disease · doi:10.1007/bf00298543 · Cited by 53
The Impact of Intestinal Failure on Oral Drug Absorption: A Review
Ward, N. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1151-9 · Cited by 53
Effects of meal and incretins in the regulation of splanchnic blood flow
Koffert, J., Honka, H., Teuho, J., Kauhanen, S. P., Hurme, S. A. M., Parkkola, R. K., Oikonen, V., Mari, A., Lindqvist, A., Wierup, N., et al. (2017) · Endocrine Connections · doi:10.1530/ec-17-0015 · Cited by 53
Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
Ouellet, D., & Pollack, G. M. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06584-5 · Cited by 52
Stappaerts, J., Wuyts, B., Tack, J. F., Annaert, P., & Augustijns, P. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.07.009 · Cited by 52
Self-citationSmits, A., Annaert, P., & Allegaert, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.035 · Cited by 50
Self-citationEffects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
Wong, G. L., Ha, V., Chu, M. P., Dersch‐Mills, D., Ghosh, S., Chambers, C. R., & Sawyer, M. B. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.11.001 · Cited by 50
Maharaj, A. R., & Edginton, A. N. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068700 · Cited by 49
Allam, O., Samarani, S., Mehraj, V., Jenabian, M.-A., Tremblay, C. L., Routy, J., Amre, D. K., & Ahmad, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194185 · Cited by 48
Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition
Scarpignato, C., & Bjarnason, I. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0726-1 · Cited by 48
Vertzoni, M., Carlsson, A., Abrahamsson, B., Goumas, K., & Reppas, C. I. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.028 · Cited by 47
Self-citationZhou, Z., Dunn, C., Khadra, I., WILSON, C. G., & Halbert, G. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.008 · Cited by 47
Self-citationAssessment of Disintegration and Dissolution of Dosage Forms In Vivo Using Gamma Scintigraphy
WILSON, C. G., & Washington, N. (1988) · Drug Development and Industrial Pharmacy · doi:10.3109/03639048809151971 · Cited by 45
Self-citationPadilla, N., Maraninchi, M., Béliard, S., Berthet, B., Nogueira, J. P., Wolff, E., Nicolay, A., Corroller, A. B., Dubois, N., Grangeot, R., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303849 · Cited by 45
Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system
Mark, E. B., Poulsen, J. L., Haase, A., Espersen, M., Gregersen, T., Schlageter, V., Scott, S. M., Krogh, K., & Drewes, A. M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13451 · Cited by 45
Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.
Cooke, E. M. (1969) · Gut · doi:10.1136/gut.10.7.565 · Cited by 44
Αbeele, J. V. D., Rayyan, M., Hoffman, I. E. A., de Vijver, E. V., Zhu, W., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.022 · Cited by 44
Self-citationAcid-Suppressive Therapy and Risk of Infections: Pros and Cons
Fisher, L., & Fisher, A. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0519-y · Cited by 43
Brussee, J. M., Vet, N. J., Krekels, E. H. J., Valkenburg, A. J., Jacqz-Aigrain, É., van Gerven, J., Swart, E. L., van den Anker, J. N., Tibboel, D., de Hoog, M., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13459 · Cited by 43
First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates
Brussee, J. M., Yu, H., Krekels, E. H. J., de Roos, B., Brill, M. J. E., van den Anker, J. N., Rostami‐Hodjegan, A., de Wildt, S. N., & Knibbe, C. A. J. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12295 · Cited by 43
Digenis, G. A., Sandefer, E. P., Page, R. C., Doll, W. J., Gold, T. B., & Darwazeh, N. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007568900147 · Cited by 42
Taggart, A. J., McDermott, B. J., & Roberts, S. D. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223040-00006 · Cited by 42
Sex and age differences in the pharmacokinetics of alosetron
Koch, K. M., Palmer, J. L., Noordin, N., Tomlinson, J. J., & Baidoo, C. A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01565.x · Cited by 42
Trevaskis, N. L., Shanker, R. M., Charman, W. N., & Porter, C. J. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0199-2 · Cited by 42
Self-citationSexual Dimorphism in Drug Metabolism and Pharmacokinetics
Valodara, A. M., & Johar, K. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666191021094906 · Cited by 42
Zhou, Q., Chen, Q.-X., Ruan, Z.-R., Yuan, H., Xu, H.-M., & Zeng, S. (2013) · Die Pharmazie · doi:10.31083/ph.2013.2742 · Cited by 42
The Role of Intestinal Bacteria in the Transformation of Sodium Picosulfate
Kim, D., Hyun, S.-H., Shim, S.-B., & Kobashi, K. (1992) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.59.1 · Cited by 41
Aburub, A., Fischer, M., Camilleri, M., Semler, J. R., & Fadda, H. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.031 · Cited by 41
Al-Gousous, J., Tsume, Y., Fu, M., Salem, I. I., & Langguth, P. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00877 · Cited by 40
Multidimensional analysis of human intestinal fluid composition
Pyper, K., Brouwers, J., Augustijns, P., Khadra, I., Dunn, C., WILSON, C. G., & Halbert, G. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.011 · Cited by 40
Self-citationTrevaskis, N. L., Lee, G., Escott, A., Phang, K. L., Hong, J., Cao, E., Katneni, K., Charman, S. A., Han, S., Charman, W. N., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00458 · Cited by 39 · cited 2×
“port increased with long-chain lipid doses up to ~130 mg/kg and then appeared to plateau at a maximum across several species (Trevaskis et al., 2020).”
BackgroundSelf-citationPollack, G. M., & Brouwer, K. L. R. (1991) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01073869 · Cited by 39
Drug disposition before and after gastric bypass: fenofibrate and posaconazole
Gesquiere, I., Hens, B., der Schueren, B. V., Mols, R., Hoon, J. N. J. M. D., Lannoo, M., Matthys, C., Foulon, V., & Augustijns, P. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13054 · Cited by 38
Self-citationNorman, J. L., Fixen, D. R., Saseen, J. J., Saba, L. M., & Linnebur, S. A. (2017) · SAGE Open Medicine · doi:10.1177/2050312117707687 · Cited by 38
Madsen, C. M., Feng, K., Leithead, A., Canfield, N., Jørgensen, S. A., Müllertz, A., & Rades, T. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.10.003 · Cited by 38
Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats
Yuan, T., Wang, J., Chen, L., Shan, J., & Di, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00597 · Cited by 38
Gesquiere, I., Darwich, A. S., der Schueren, B. V., Hoon, J. N. J. M. D., Lannoo, M., Matthys, C., Rostami‐Hodjegan, A., Foulon, V., & Augustijns, P. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12666 · Cited by 36
Self-citationThe influence of gastrointestinal transit on drug absorption in healthy volunteers.
Riley, S., Sutcliffe, F., Kim, M., Kapás, M., Rowland, M., & Turnberg, L. A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04104.x · Cited by 35
Augustijns, P., Vertzoni, M., Reppas, C. I., Langguth, P., Lennernäs, H., Abrahamsson, B., Hasler, W. L., Baker, J. R., Vanuytsel, T., Tack, J. F., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105517 · Cited by 35
Self-citationYago, M. R., Frymoyer, A. R., Benet, L. Z., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9673-9 · Cited by 34
Drug–drug interactions in patients receiving tyrosine kinase inhibitors
Keller, K. L., Franquiz, M. J., Duffy, A. P., & Trovato, J. A. (2016) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155216682311 · Cited by 33
Vermeulen, M. A. R., Richir, M. C., Garretsen, M. K., van Schie, A., Ghatei, M. A., Holst, J. J., Heijboer, A. C., Uitdehaag, B. M. J., Diamant, M., Eekhoff, E. M. W., et al. (2011) · Nutrition · doi:10.1016/j.nut.2010.10.001 · Cited by 32
Keunecke, A., Hoefman, S., Drenth, H., Zisowsky, J., Cleton, A., & Ploeger, B. A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14334 · Cited by 32
Nuclear receptors, bile acids and cholesterol homeostasis series – Bile acids and pregnancy
Abu‐Hayyeh, S., Papacleovoulou, G., & Williamson, C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.027 · Cited by 31
Knorr, J. P., Sjeime, M., Braitman, L. E., Jawa, P., Zaki, R. F., & Ortiz, J. (2013) · Transplantation · doi:10.1097/01.tp.0000436100.65983.10 · Cited by 31
van Groen, B. D., Krekels, E. H. J., Mooij, M. G., van Duijn, E., Vaes, W. H. J., Windhorst, A. D., van Rosmalen, J., Hartman, S. J. F., Hendrikse, N. H., Koch, B. C. P., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1890 · Cited by 31
Self-citationYücel, E., Sancar, M., Yücel, A., & Okuyan, B. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1128413 · Cited by 30
Litou, C., Vertzoni, M., Xu, W., Kesisoglou, F., & Reppas, C. I. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.009 · Cited by 30
Self-citationYu, A., Jackson, T., Tsume, Y., Koenigsknecht, M., Wysocki, J., Marciani, L., Amidon, G. L., Frances, A., Baker, J. R., Hasler, W., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0145-x · Cited by 30
Petrakis, O., Vertzoni, M., Angelou, A., Kesisoglou, F., Bentz, K., Goumas, K., & Reppas, C. I. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12320 · Cited by 29
Self-citationZimmermann, T., Laufen, H., Yeates, R. A., Scharpf, F., Riedel, K., & Schumacher, T. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922011782 · Cited by 29
Boosting drug bioavailability in men but not women through the action of an excipient
Mai, Y., Ashiru-Oredope, D. A. I., Yao, Z., Dou, L., Madla, C. M., Taherali, F., Murdan, S., & Basit, A. W. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119678 · Cited by 28 · cited 2×
“20 transporter P-gp were significantly higher in females than males due to the innately higher expression of P-gp in the proximal small intestine of males (Mai et al., 2020).”
BackgroundSelf-citationWillmann, S., Edginton, A. N., Kleine-Besten, M., Jantratid, E., Thelen, K., & Dressman, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0008 · Cited by 28
Pohl, O., Osterloh, I. H., Lecomte, V., & Gotteland, J. (2012) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201789 · Cited by 28
Drug Absorption VII: Influence of Mesenteric Blood Flow on Intestinal Drug Absorption in Dogs
Crouthamel, W. G., Diamond, L., Dittert, L. W., & Doluisio, J. T. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640420 · Cited by 28
Litou, C., Effinger, A., Kostewicz, E. S., Box, K. J., Fotaki, N., & Dressman, J. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12983 · Cited by 27
Mai, Y., Liu, D., Madla, C. M., Murdan, S., & Basit, A. W. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11050228 · Cited by 27
Self-citationGastrointestinal pH and transit times in healthy subjects with ileostomy
Fallingborg, J., Christensen, L. A., Ingeman‐Nielsen, M., Jacobsen, B. A., ABILDGAARD, K., Rasmussen, H. H., & Rasmussen, S. N. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00469.x · Cited by 26
Drug absorption from the small intestine in immediate postoperative patients
Kennedy, J., & van Rij, A. M. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael117 · Cited by 26
Human intestinal fluid factors affecting intestinal drug permeation in vitro
Riethorst, D., Brouwers, J., Motmans, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.06.007 · Cited by 26
Self-citationWalsh, J., Gheorghe, C. E., Lyte, J. M., van de Wouw, M., Boehme, M., Dinan, T. G., Cryan, J. F., Griffin, B. T., Clarke, G. A., & Hyland, N. P. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13276 · Cited by 26
Self-citationWhite, K. L., Nguyen, G., Charman, W. N., Edwards, G. A., Faassen, W. A., & Porter, C. J. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154542 · Cited by 25
Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable
Moore, K. L., Patel, K., Boscardin, W. J., Steinman, M. A., Ritchie, C. S., & Schwartz, J. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196109 · Cited by 23
Pentafragka, C., Vertzoni, M., Symillides, M., Goumas, K., & Reppas, C. I. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105351 · Cited by 23
Self-citationThe role of osmolality in the absorption of a nutrient solution
Pfeiffer, Schmidt, & Kaess (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00301.x · Cited by 19
Oro‐cecal transit time: influence of a subsequent meal
Priebe, M. G., Wachters-Hagedoorn, R. E., Stellaard, F., Heiner, A. M., Elzinga, H., & Vonk, R. J. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01357.x · Cited by 19
Elvang, P. A., Bohsen, M. S., Stein, P. C., Bauer‐Brandl, A., Riethorst, D., Brouwers, J., Augustijns, P., & Brandl, M. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.03.026 · Cited by 19
Self-citationXu, J., Lin, Y., Boulas, P., & Peterson, M. L. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1389889 · Cited by 18
Intestinal permeability and autoimmune diseases
Smyth, M. C. (2017) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzx015 · Cited by 18
Systematic review of drug bioavailability following gastrointestinal surgery
Santamaría, M. M., Villafranca, J. A., Abilés, J., López, A. F., Rodas, L. V., Goitia, B. T., & Navarro, P. U. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2539-9 · Cited by 18
Zhou, J., Quinlan, M., Glenn, K., Boss, H., Picard, F., Castro, H. J., & Sellami, D. B. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13038 · Cited by 17
Senek, M., Nyholm, D., & Nielsen, E. I. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2497-2 · Cited by 17
Jin, L., Pan, Y., Tran, N. L. L., Polychronopoulos, L. N., Warrier, A., Brouwer, K. L. R., & Nicolazzo, J. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01227 · Cited by 17
Vertzoni, M., Sulaiman, S., Goumas, K., Kersten, E., Anlahr, J., Muenster, U., & Reppas, C. I. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.029 · Cited by 17
Self-citationSex and Food Influence on Intestinal Absorption of Ketoprofen Gastroresistant Formulation
Magallanes, L., Lorier, M., Ibarra, M., Guevara, N., Vázquez, M., & Fagiolino, P. L. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.208 · Cited by 16
Review: Medication Delivery in the Short‐Bowel Syndrome
McFadden, M. A., DeLegge, M. H., & Kirby, D. F. (1993) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607193017002180 · Cited by 16
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam
Tomalik‐Scharte, D., Doroshyenko, O., Kirchheiner, J., Jetter, A., Lazar, A., Klaassen, T., Frank, D., Wyen, C., Fätkenheuer, G., & Fuhr, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0503-9 · Cited by 16
Influence of a subsequent meal on the oro‐cecal transit time of a solid test meal
Priebe, M. G., Wachters-Hagedoorn, R. E., Landman, K., Heimweg, J., Elzinga, H., & Vonk, R. J. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01601.x · Cited by 16
Enterohepatic recycling of estrogen and its relevance with female fertility
Sher, A., & Rahman, M. A. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976582 · Cited by 16
Effects of Intestinal Flora on the Expression of Cytochrome P450 3A in the Liver
Ishii, M., Toda, T., Ikarashi, N., Ochiai, W., & Sugiyama, K. (2012) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.132.301 · Cited by 15
Karatza, E., Goumas, C., Muenster, U., Reppas, C. I., & Vertzoni, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.015 · Cited by 15
Self-citationComplex influences of gut microbiome metabolism on various drug responses
Chae, S., Kim, D. J., & Cho, J. (2020) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2020.28.e3 · Cited by 14
Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome
Wauters, L. I., & Vanuytsel, T. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.09.005 · Cited by 13
Self-citationMonosodium glutamate inhibits the lymphatic transport of lipids in the rat
Kohan, A. B., Yang, Q., Xu, M., Lee, D., & Tso, P. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00342.2014 · Cited by 12
Faber, K. P., Wu, H.-F., Yago, M. R., Xu, X., Kadiyala, P., Frassetto, L. A., & Benet, L. Z. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2090-2 · Cited by 12
Gender Differences in the Gut Microbiome and How These Affect Cardiovascular Diseases
Rosel, A. C., Wassenaar, T. M., & Ussery, D. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-71135-5_7 · Cited by 11
Abuhelwa, A. Y., Mudge, S., Upton, R. N., & Foster, D. J. R. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0519-1 · Cited by 11
[Sex differences in drug action: the role of multidrug-resistance proteins (MRPs)].
Smirnova, O. V. (2012) · PubMed · Cited by 9
Xu, L., Nagasawa, N., Yoshii, F., & Kume, T. (2003) · Journal of Applied Polymer Science · doi:10.1002/app.12370 · Cited by 8
Sakuma, S., 小倉, 涼., Masaoka, Y., Kataoka, M., Tanno, F. K., Kokubo, H., & Yamashita, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21716 · Cited by 7
Exploring the Impact of Intestinal Fluid Components on the Solubility and Supersaturation of Danazol
Madsen, C. M., Plum, J., Hens, B., Augustijns, P., Müllertz, A., & Rades, T. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.039 · Cited by 7
Self-citation
Cited by
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Park, H., Otte, A., & Park, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.030 · Cited by 475
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
“Additionally, depending on the chemical composition, formulation and administration route, antibiotics have different propensities to bioaccumulate in the gastrointestinal tract 73 ; this undoubtedly has a role in determining the magnitude of microbiome perturbation.”
BackgroundConnected healthcare: Improving patient care using digital health technologies
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J., Elbadawi, M., McCoubrey, L. E., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113958 · Cited by 405
Self-citationThe Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Metadata
- Authors
- Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., Keszthelyi, D., Koziolek, M., Madla, C. M., Matthys, C., McCoubrey, L. E., Mitra, A., Reppas, C., Stappaerts, J., Steenackers, N., Trevaskis, N. L., Vanuytsel, T., Vertzoni, M., Weitschies, W., Wilson, C., & Augustijns, P.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 162
- Pages
- 105812
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W3138845742
- Cited by
- 359
- References
- 332
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.